THERE is increasing evidence recently to suggest that patients suffering from Burkitt tumour produce factors of a specific immunological character directed against antigens in the tumour. Burkitt et al. (1965) considered that there is probable participation of immunological processes in the manifestation of certain clinical observations made on patients suffering from the tumour. In particular, the dramatic response of the tumour to unusually low doses of certain cytotoxic drugs, failure of subsequent tumours to appear at sites of completely regressed tumour, and the many cases of authentic long term remissions were believed to be due, at least in part, to host defence mechanisms directed against the tumour.
The concept was further supported by the independent reports by Ngu (1966) and Burkitt (1966) of almost complete, though transient, regression of jaw tumours in two Burkitt tumour patients infused with plasma from cases in long term remissions.
Suggestive laboratory evidence were also forthcoming. Using fluorescent antibody tests, Klein et al. (1966) were able to demonstrate innumological reaction between the cell surface of freshly isolated Burkitt tumour cells and serum globulins from a good number of Burkitt tumour patients as well as some adult patients with other diseases, in East Africa. Osunkoya (1966) suggested that the relative poor growth of a Burkitt tumour cell line in cultures containing sera from some Birkitt tumour patients as compared with sera from healthy Nigerian children and adults may be due to anti-tumour humoral factors present in the serum of these patients.
In the present study, two parameters-growth effect and membrane immunofluorescence-were used in the comparison of the effects of serum from various groups of individuals on a long established Burkitt tumour cell line. A third parameter, that of detection of cytotoxic antibodies by the in vitro cytotoxic test of Gorer and O'Gorman (1956) is the basis of a parallel study to be published elsewhere.
MATERIALS AND METHODS
Birkcitt tumour cellB.-The target cells used in these series of experiments were lymphoid cells (Strain OB3) established in continuous suspension culture from ascitic fluid of a Nigerian boy aged 10 years suffering from abdominal Burkitt tumour. The cells have been maintained in culture for about nine months at the time they were tested. Cultures were maintained in medium TC 199 containing 25 to 30% pooled human serum obtained from Nigerian blood donors at U.C.H., Ibadan, and supplemented with 0.4% chick embryo extract (Difco). Neomycin (30 units/ml.) and mycostatin (50 units/ml.) were added to all cultures. The cells grow readily in small aggregates with many single free floating cells present.
Viable Burkitt tumour cells harvested from stock cultures maintained in this laboratory have been observed (unpublished) to regularly show a positive membrane immunofluorescence when simply washed thrice in phosphate buffered saline (PBS) pH 7-2, and stained with fluorescein-labelled anti-human globulin. The membrane immunofluorescence is totally prevented if the harvested cells are exposed to 0.25% trypsin in TC 199 for 30 minutes, at 370 C., before washing in three changes of PBS, pH 7-2. Test sera.-Single blood samples were obtained from the various groups of individuals listed in Tables I and II (i) . (Moller, 1961) .
(i) Growth Experiments.-The layout of the experiments was as described in a previous report (Osunkoya, 1966) (Osunkoya, 1965) 
RESULTTS

Growth Experiments
The growth index of serum samples from the different groups of individuals is as shown in the scattergram (Fig. 1) . There was wide variation in the growth effect of the test sera on OB3 cells. The widest variation was in the Nigerian blood donor group with growth indices ranging from -20 to +500. (Table I) with a median value of +120. There was no significant difference between the effects of sera from Negro and Caucasian New York citizens, median values being + 70 and + 80 respectively. Both groups however, lack individuals with unusually high growth promoting effect present in the adult Nigerian group. The effect, if any, of shipping on the growth effect of sera from New York is yet to be determined.
The Peace Corps groups show a distribution not unlike those of Nigerian blood donors, the long resident members of the corps tending to manifest lower growth indices. The numbers tested in the Peace Corps sub-groups were unfortunately too small to allow definite conclusions to be drawn from the apparent difference between the newly arrived (median, + 220) and the long resident members (median, + 130) of the American Peace Corps in Nigeria.
As a group, the sera from Burkitt tumour patients showed the lowest growth promoting effects. The growth index range was -110 to +250. In this group sera from patients in remission showed lower growth promoting effects (median +40) than in the untreated tumour-bearing patients (median +60). The three patients with the lowest growth indices had been symptom-free 2 or more years after treatment.
The distribution of growth indices of sera from parents of Burkitt tumour patients, patients with malignant lymphoma other than Burkitt tumour, and other sick children of the same age group as Burkitt tumour patients were essentially within the range of those of healthy Nigerian blood donors. The two sick children with sera with unusually low growth indices ( Fig. 1) There was no correlation between the growth effect or outcome of the fluorescent antibody tests of sera from the Nigerian donors and their respective ABO and Rh blood groups. There was also no correlation between the growth effect of individual serum samples and their respective membrane immunofluorescence reaction on OB3 cells. Thus, a serum sample with a low growth index did not necessarily give a positive membrane immunofluorescence reaction.
DISCUSSION
The knowledge gained in the growth experiments is closely similar to that reported in an earlier study in which another Burkitt tumour cell line (Strain OB1) and a different series of sera from adult Nigerians and Burkitt tumour patients were tested, (Osunkoya, 1966) .
It is likely, as has already been suggested, that several factors particularly of a nutritional nature are involved, in addition to probable immunological processes, in the manifestation of the effect of a serum sample on the growth of Burkitt tumour cells in vitro. The active participation of immune or related processes is however suggested by the trend observed by Ngu et al. (1966) between the lgM level of some serum samples and their growth effects on a Burkitt tumour cell line (OB6).
It is well known in tissue culture work that some human and animal sera contain thermolabile substances of as yet unknown nature, which make such sera " toxic " to cell growth in vitro. An immunological phenomenon is still to be excluded in the search for a satisfactory explanation to account for the action of these " toxic " sera. Sera heated at 560 C. for 30 minutes regularly have a lower growth index than the respective uninactivated serum when tested on Burkitt tumour cell lines, (unpublished).
The result of the immunofluorescence tests on OB3 cells cultured in sera from various individuals are of interest, and essentially confirms the results of Klein et al. (1966) concerning East Africans. Sera from Swedish blood donors tested by these workers were however negative.
Several conclusions are readily drawn from the set of figures shown in Table II . We can now say that (i) cells that have been propagated in tissue culture for more than nine months after isolation from a patient suffering from Burkitt tumour bear on their surface moieties perhaps of an antigenic character, which react with human serum globulins to such a degree as to be detectable by the indirect (sandwich) fluorescent antibody reaction. The interpretation of these findings can, at this stage of our studies, be only a matter of conjecture. If the positive " ring " test (Moller, 1961 ) is a genuine index of an immunological reaction, then it would appear that antibodies to surface antigens on OB3 cells are present in detectable concentration in a little less than half of Nigerian blood donors, and about a fifth of New York blood donors. The incidence of positive individuals is quite low in Nigerian children unless they are suffering or have suffered from Burkitt tumour.
The nature of the reactant antigens on the surface of Burkitt tumour cells is not known. The probability that the antigens are Burkitt tumour specific has much to commend itself, but several other possibilities have to be considered for exclusion, particularly if cell lines are used in the search for experimental proof of this surmise.
The non-correlation of positive sera with ABO and rhesus blood group of donors has been mentioned already. The combined incidence of Anti-M, N and S haemagglutinins in the sera of Nigerian blood donors is less than 10% (Luzzatto personal communication), a figure too low to account for an incidence of over 40% positive sera in the Nigerian blood donors studied. Klein et al. (1966) were also able to exclude the involvement of blood group antigens in the analysis of their results.
The increasing reports of contamination of cell cultures by pleuropneumonialike organisms (PPLO), with their characteristic tendency to aggregate on cell surfaces, brings this class of organisms under consideration in any immunological tests involving the cell surface of cultured cells (Edwards and Fogh, 1960; Kraemer et al., 1963; Fogh and Fogh, 1964; Holmgren find Payne, 1966) . Electron microscopic examination have so far failed to demonstrate Mycoplasma (PPLO) in OB3 cultures (Dalton, personal communication) .
The attractive hypothesis of virus-induced, insect-vectored aetiology of Burkitt tumour (Davies, quoted by Burkitt, 1962a; Burkitt, 1962b; Stanley, 1966) has given much impetus to the search for viral agents in Burkitt tumour materials. Herpes-type virus particles have been demonstrated in several Burkitt tumour cell lines (Epstein et al., 1964 (Epstein et al., , 1965 Stewart et al., 1965; Rabson et al., 1966 (Woodall et al., 1965; Simons and Ross, 1965. Dalldorf and Bergmaini (1964) isolated filterable antigenically-related agents now known to be mycoplasma from tumour, bone marrow and faeces of six out of eight East African children suffering from Burkitt tumour. Lastly, reovirus type 3, a virus whose exact role, if any, in the pathogenesis of murine lymphoma is as yet not clear, (Stanley, 1966; Stanley et al., 1966(b) ) have also been isolated from Burkitt tumour biopsy materials, including ascitic fluid Bell, 1966) .
There is striking similarity between the results of the present investigations and reports on some serological investigations carried out in East Africa in which it was shown that 53 out of 72 (73%) Burkitt tumour patients had demonstrable antibodies to reovirus type 3 as compared with 12 out of 65 (18%) healthy East African children, a highly significant difference, (Bell, 1966) .
While awaiting the characterisation of the cell surface antigens on OB3 and other Burkitt tumour cells, the results of the present study would suggest that some of these antigens may be related to the pathogenesis of Burkitt tumour, since it is children with this tumour as well as their relatives that produced the highest incidence of positive sera. This conclusion supports the concept of Burkitt tumour being a rare aberrant response to an infective, probably viral agent which occurs commonly in tropical Africa. (Haddow and McCallum, 1962; Burkitt, 1963) . It is possible that this agent or a closely related variant also occurs in and around New York. It is considered that ease of perpetuation and transmission, and more frequent exposure to the agent may account for the relatively higher incidence of Burkitt's tumour in Africa.
* Two months after this paper was submitted for publication, occasional herpes-like virus particles were seen in a few OB3 cells by electron microscopy. (V. H. Zeve, 1966, personal communication) .
SUMMARY
(1) Sera from various individuals were tested on cells from a Burkitt tumour cell line (OB3), for effect on growth of these cells in vitro, and for presence of antibodies to surface antigens on these cells.
(2) Sera from Burkitt tumour patients, particularly those in long-term remission, have relatively low growth promoting effects on OB3 cells.
(3) Using the indirect immunofluorescence reaction, antibodies to surface antigens on living OB3 cells were detected in serum samples from a little less than half of Nigerian blood donors, as compared with a fifth of New York blood donors tested (p < 0.005). There was no significant difference in the incidence of positive sera between Negro and Caucasian New York blood donors. The incidence of positive sera was quite low in sick Nigerian children unless they are suffering or have suffered from Burkitt tumour (p < 0.025). Although a higher proportion of young Americans resident in Nigeria produced positive sera than a comparable newly arrived group, and although it would appear that the incidence of positive sera was highest in the parents of Burkitt tumour patients the small numbers tested in these groups preclude statistical significance.
(4) The nature of the surface antigens on Burkitt tumour cells is discussed in the light of the above findings. It is considered that these antigens are related to the aetiogenesis of Burkitt tumour, and may be infective in origin.
(5) There was no correlation between the growth effect of serum samples and their respective membrane immunofluorescence results.
